Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marion Stevense - den Boer"'
Autor:
Olivier J. van Not, Thijs T. Wind, Rawa K. Ismail, Arkajyoti Bhattacharya, Mathilde Jalving, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, John B. Haanen, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Rozemarijn S. van Rijn, Marion Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Willeke A. M. Blokx, Karijn P. M. Suijkerbuijk, Rudolf S. N. Fehrmann, Geke A. P. Hospers
Publikováno v:
Cancers, 15(11):2922. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 15, 11
Cancers, 15
van Not, O J, Wind, T T, Ismail, R K, Bhattacharya, A, Jalving, M, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, van den Eertwegh, A J M, de Groot, J W B, Haanen, J B, Kapiteijn, E, Bloem, M, Piersma, D, van Rijn, R S, Stevense-den Boer, M, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Blokx, W A M, Suijkerbuijk, K P M, Fehrmann, R S N & Hospers, G A P 2023, ' A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors ', Cancers, vol. 15, no. 11, 2922 . https://doi.org/10.3390/cancers15112922
Cancers; Volume 15; Issue 11; Pages: 2922
Cancers, 15, 11
Cancers, 15
van Not, O J, Wind, T T, Ismail, R K, Bhattacharya, A, Jalving, M, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, van den Eertwegh, A J M, de Groot, J W B, Haanen, J B, Kapiteijn, E, Bloem, M, Piersma, D, van Rijn, R S, Stevense-den Boer, M, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Blokx, W A M, Suijkerbuijk, K P M, Fehrmann, R S N & Hospers, G A P 2023, ' A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors ', Cancers, vol. 15, no. 11, 2922 . https://doi.org/10.3390/cancers15112922
Cancers; Volume 15; Issue 11; Pages: 2922
Contains fulltext : 293454.pdf (Publisher’s version ) (Open Access) The efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced melanoma that develop brain metastases (BM) remains unpredictable. In this study, we aimed to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcaef79c1a9e25c917f0c8902b4dea0
https://research.vumc.nl/en/publications/3986ca38-c595-4d53-a8ce-8e61d59ddcb4
https://research.vumc.nl/en/publications/3986ca38-c595-4d53-a8ce-8e61d59ddcb4
Autor:
Melissa M. De Meza, Willeke A. M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers, Ellen Kapiteijn, Olivier J. Van Not, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense-den Boer, Astrid A. M. Van der Veldt, Gerard Vreugdenhil, Alfonsus J. M. Van den Eertwegh, Karijn P. M. Suijkerbuijk, Michel W. J. M. Wouters
Publikováno v:
Cancers, 15(2):409. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 15(2). MDPI
Cancers, 15, 2
de Meza, M M, Blokx, W A M, Bonenkamp, J J, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J W B, Haanen, J B A G, Hospers, G A P, Kapiteijn, E, van Not, O J, Piersma, D, van Rijn, R S, Stevense-den Boer, M, van der Veldt, A A M, Vreugdenhil, G, van den Eertwegh, A J M, Suijkerbuijk, K P M & Wouters, M W J M 2023, ' Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma : A Propensity-Matched Outcome Analysis ', Cancers, vol. 15, no. 2, 409 . https://doi.org/10.3390/cancers15020409
Cancers; Volume 15; Issue 2; Pages: 409
Cancers, 15
Cancers, 15(2). MDPI
Cancers, 15, 2
de Meza, M M, Blokx, W A M, Bonenkamp, J J, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J W B, Haanen, J B A G, Hospers, G A P, Kapiteijn, E, van Not, O J, Piersma, D, van Rijn, R S, Stevense-den Boer, M, van der Veldt, A A M, Vreugdenhil, G, van den Eertwegh, A J M, Suijkerbuijk, K P M & Wouters, M W J M 2023, ' Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma : A Propensity-Matched Outcome Analysis ', Cancers, vol. 15, no. 2, 409 . https://doi.org/10.3390/cancers15020409
Cancers; Volume 15; Issue 2; Pages: 409
Cancers, 15
Simple Summary BRAF/MEK therapy and anti-PD-1 therapy have shown better recurrence-free survival of stage III melanoma in patients with BRAF V600 mutations in clinical trials. However, little is known about how these therapies compare to each other i
Autor:
Olivier J. van Not, Willeke A.M. Blokx, Alfons J.M. van den Eertwegh, Melissa M. de Meza, John B. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Marion Stevense-den Boer, Astrid A.M. van der Veldt, Marye J. Boers-Sonderen, Anne M.L. Jansen, Michel W.J.M. Wouters, Karijn P.M. Suijkerbuijk
Publikováno v:
JCO Precision Oncology, 6:e2200018. American Society of Clinical Oncology
JCO Precision Oncology, 6
JCO Precision Oncology, 6:e2200018. AMER SOC CLINICAL ONCOLOGY
JCO Precision Oncology, 6
JCO Precision Oncology, 6:e2200018. AMER SOC CLINICAL ONCOLOGY
PURPOSE Little is known about the effect of specific gene mutations on efficacy of immune checkpoint inhibitors in patients with advanced melanoma. MATERIALS AND METHODS All patients with advanced melanoma treated with first-line anti–PD-1 or ipili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a14d11d0fa70f6a29c2366447ae5ff
https://doi.org/10.1200/PO.22.00018
https://doi.org/10.1200/PO.22.00018
Autor:
Melissa Melanie de Meza, Willeke Blokx, Han J. Bonenkamp, Christian U. Blank, Maureen J.B. Aarts, Franchette Van Den Berkmortel, Marye J. Boers-Sonderen, Jan Willem de Groot, John B. A. G. Haanen, Geke Hospers, Ellen Kapiteijn, Olivier Jules van Not, Djura Piersma, Rozemarijn Van Rijn, Marion Stevense - den Boer, Astrid Aplonia Maria Van Der Veldt, Gerard Vreugdenhil, Alfonsus Johannes Maria van den Eertwegh, Karijn Suijkerbuijk, Michel W.J.M. Wouters
Publikováno v:
Journal of Clinical Oncology. 40:9577-9577
9577 Background: Few clinical trials address the efficacy of adjuvant systemic treatment in patients with ITM. This study describes the efficacy of adjuvant systemic therapy of ITM patients beyond the clinical trial setting. Methods: All stage III ad
Autor:
Olivier Jules van Not, Rik Jasper Verheijden, Alfonsus Johannes Maria van den Eertwegh, John B. A. G. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette Van Den Berkmortel, Jan Willem de Groot, Geke Hospers, Ellen Kapiteijn, Melissa Melanie de Meza, Djura Piersma, Rozemarijn Van Rijn, Marion Stevense - den Boer, Astrid Aplonia Maria Van Der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Willeke Blokx, Michel W.J.M. Wouters, Karijn Suijkerbuijk
Publikováno v:
Journal of Clinical Oncology. 40:9546-9546
9546 Background: Management of checkpoint-inhibitor-induced immune-related adverse events (irAEs) is primarily based on expert opinion. Recent studies have suggested detrimental effects of immunosuppressive treatment with anti-TNF on checkpoint-inhib